<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7605074</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6087</journal-id>
<journal-id journal-id-type="nlm-ta">Neuroscience</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuroscience</journal-id>
<journal-title-group>
<journal-title>Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0306-4522</issn>
<issn pub-type="epub">1873-7544</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29183825</article-id>
<article-id pub-id-type="pmc">5766367</article-id>
<article-id pub-id-type="doi">10.1016/j.neuroscience.2017.11.037</article-id>
<article-id pub-id-type="manuscript">NIHMS922782</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chronic intranasal oxytocin has dose-dependent effects on central oxytocin and vasopressin systems in prairie voles (<italic>Microtus ochrogaster</italic>)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Guoynes</surname>
<given-names>C.D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Simmons</surname>
<given-names>T.C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Downing</surname>
<given-names>G.M.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacob</surname>
<given-names>S.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Solomon</surname>
<given-names>M.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bales</surname>
<given-names>K.L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychology and California National Primate Research Center, University of California, Davis, CA</aff>
<aff id="A2">
<label>2</label>Department of Psychology, University of Wisconsin, Madison, WI</aff>
<aff id="A3">
<label>3</label>Department of Biology, San Francisco State University, San Francisco, CA</aff>
<aff id="A4">
<label>4</label>Department of Psychiatry and Center for Neurobehavioral Development, University of Minnesota, MN</aff>
<aff id="A5">
<label>5</label>Department of Psychiatry and Behavioral Sciences and MIND Institute, University of California, Davis, CA</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Karen Bales, <email>klbales@ucdavis.edu</email>, Phone: 530-754-5890, Fax: 530-752-2087. Present address: One Shields Avenue, Department of Psychology, University of California, Davis, CA</corresp>
<fn fn-type="equal" id="FN2">
<label>*</label>
<p>Both authors contributed equally to this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>25</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>369</volume>
<fpage>292</fpage>
<lpage>302</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuroscience.2017.11.037-->
<abstract>
<p id="P2">Oxytocin (Oxt) is a neuropeptide with many functions, including modulation of social behavior(s) and anxiety. Due to its notable pro-social effects, it has been proposed as a treatment in the management of neuropsychiatric disorders, such as autism spectrum disorder (ASD), schizophrenia, and social anxiety; however, effects of long-term daily treatment are still being explored. Previously, we have shown that in male prairie voles (<italic>Microtus ochrogaster)</italic> exposure to Oxt during the peri-adolescent period impaired adult pair bonding in a dose-dependent fashion. In females, the medium dose used (0.8 IU/kg) appeared to facilitate pair bonding, and the low and medium doses were associated with fewer lines crossed in the open field. In this study, we examined central receptor binding and immunoreactive (IR) protein for Oxt and vasopressin (Avp), a closely related peptide. Voles were treated with saline vehicle, or one of three doses of Oxt (0.08, 0.8, 8.0 IU/kg) for three weeks from postnatal days 21–42, and euthanized as adults. We used autoradiography to examine Oxt and Avp receptor binding and immunohistochemistry to examine Oxt and Avp –immunoreactive cells in the paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus. Females that received the medium dose of Oxt had higher Oxt receptor binding in the nucleus accumbens shell (NAS), while males that received the medium dose had lower Avp-immunoreactive cells in the PVN. In summary, we found sex-specific effects of long-term exposure to intranasal Oxt on the Oxt and Avp systems at the weight-adjusted dose currently being used in clinical trials in humans.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>